REQUEST A DEMO
Total
USD $0.00
Search more companies

Spirit Scientific Co. Ltd. (思必瑞特生技股份有限公司) (Taiwan, China)

Main Activities: Research and Development in Nanotechnology
Full name: Spirit Scientific Co. Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

The main business projects of the Company and its subsidiaries are blood growth factor cryotherapy services. The Company was established in 2020 and is headquartered in New Taipei City, Taiwan.

Headquarters
19F-12, No. 93, Sec. 1 Xintai 5Th Rd Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Spirit Scientific Co. Ltd. (思必瑞特生技股份有限公司) report to view the information.

Website: http://www.sslab.com

Basic Information
Outstanding Shares:
Purchase the Spirit Scientific Co. Ltd. (思必瑞特生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Spirit Scientific Co. Ltd. (思必瑞特生技股份有限公司) report to view the information.
Incorporation Date:
December 06, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Subsidiaries
Spirit Scientific Japan Co., Ltd. (Japan)
100%
Company Performance
Financial values in the chart are available after Spirit Scientific Co. Ltd. (思必瑞特生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
39.02%
Total operating revenue
39.52%
Operating profit (EBIT)
174.24%
EBITDA
92.94%
Net Profit (Loss) for the Period
232.39%
Total assets
18.79%
Total equity
19.4%
Operating Profit Margin (ROS)
6.12%
Net Profit Margin
6%
Return on Equity (ROE)
2.57%
Debt to Equity Ratio
2.93%
Quick Ratio
0.13%
Cash Ratio
1.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?